FEAM Newsletter – May 2022

In this month's newsletter, we share an overview on the activities that FEAM is developing, such as the organisation of theinternational conference on combatting zoonoses and addressing AMR on the Planet with a One Health Approach.

25 / 05 / 2022

Summary Report: Pharmaceuticals in the Environment

On 29 March 2022, the FEAM European Biomedical Policy Forum, with the support of the Federation of Veterinarians of Europe (FVE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), organised an online event on ‘Pharmaceuticals in the Environment’. The summary report, with the main conclusions of the event, is now available.

29 / 04 / 2022

FEAM Newsletter – March 2022

In this month's newsletter, we share an overview on the activities that FEAM is developing, such as the publication of the reports on Cancer Screening and Adult Vaccination, and the PERISCOPE MOOC on One Health. 

28 / 03 / 2022

Immunisation for old adults in Europe: scientific and social strategies report

On 9 March, the Federation of European Academies of Medicine (FEAM) published the report 'Immunisation for old adults in Europe: scientific and social strategies'. The document outlines several guidelines on the future of adult vaccination in Europe.

09 / 03 / 2022

Statement by the FEAM Board on the health and biomedical research impact of the war in Ukraine

We would like to express our deep concern for loss of life and the potential humanitarian disaster triggered by the war in Ukraine. We express solidarity with the people of Ukraine and with scientists and physicians whose livelihood and research are jeopardized and may be destroyed by the current Russian invasion. We call on our National Academies to express their solidarity with the biomedical community in Ukraine and to highlight the need to maintain and provide adequate support for continued research cooperation and training during these chaotic times.

04 / 03 / 2022

Group of Chief Scientific Advisors Scientific Opinion on Cancer Screening in the European Union

This scientific opinion of the Group of Chief Scientific Advisors (GCSA), published on 2 March 2022, informed by an evidence review report by experts of the Science Advice for Policy by European Academies (SAPEA) consortium, and extensive reviews of scientific literature and clinical trials through rapid reviews, examines how to improve cancer screening in Europe.

02 / 03 / 2022

Improving Cancer Screening in the European Union – SAPEA report

In a comprehensive evidence review published on 2 March, SAPEA – part of the Commission’s Scientific Advice Mechanism – evaluates improvements to existing screening programmes for cervical cancer, breast cancer and colorectal cancer — by adopting new technologies, expanding the age range of screening, and optimising how frequently people are screened depending on age, sex and previous test results.

02 / 03 / 2022

Summary Report: How should Europe prepare and respond to cross-border health  threats: HERA?

On 31 January 2022, the Federation of European Academies of Medicine (FEAM), and the four French Academies of Medicine, of Veterinary Sciences, of Pharmacy and of Agriculture, organized the workshop ‘How should Europe prepare and respond to cross-border health threats: HERA?‘. The summary report of the event is now available. You can now read the experts' views on Europe's role in cross-border health crisis preparedness and response.

21 / 02 / 2022

Rapport Sommaire: Comment l’Europe doit-elle se préparer et répondre aux menaces pour la santé: HERA?

Le 31 janvier 2022, la Fédération des académies de médecine européennes (FEAM) et les quatre académies françaises de médecine, des sciences vétérinaires, de pharmacie et d'agriculture ont organisé l'atelier "Comment l'Europe doit-elle se préparer et répondre aux menaces sanitaires transfrontalières: HERA ?". Le rapport de synthèse de l'événement est maintenant disponible. Vous pouvez maintenant lire les opinions des experts sur le rôle de l'Europe dans la préparation et la réponse aux crises sanitaires transfrontalières.

21 / 02 / 2022

FEAM Newsletter – January 2022

In this month's newsletter, we share an overview on the activities is developing at the moment, such as the workshop on "How Europe should prepare and respond to cross-border health threats", the Cancer Screening Report and the consultancy services we are providing to DG SANTE.

02 / 02 / 2022

Summary Report: FEAM Annual Lecture 2021 – Drug Development

On 25 November, the FEAM Forum organized its 2021 Annual Lecture, this year under the topic, "Fastening EU Drug Development". The event, sponsored by Novartis, gathered members of academia, polictics, patients' groups and industry in a roundtable discussion.

06 / 01 / 2022

European Health Stakeholder Group Statement: Formalising the UK’s association to Horizon Europe

As representatives of the European Union’s health community, we are united in our call for the United Kingdom’s association to Horizon Europe to be formalised as soon as possible. Horizon Europe aims to tackle the major global challenges of our time but achieving this aim will be impossible without international collaboration

09 / 12 / 2021

Summary of FEAM session on “COVID-19 impacts on health” at 9th congress of Carol Davila University of Medicine and Pharmacy of Bucharest – 25 November 2021

On 25 November 2021, the Federation of European Academies of Medicine (FEAM) organised an online session at the 9th Congress of Carol Davila University of Medicine and Pharmacy of Bucharest focusing on COVID-19 impacts on mental health and health inequalities. Here you can find the summary of the event.

07 / 12 / 2021

AMR Stakeholder Network – Position paper on the EU Pharmaceutical strategy

Antimicrobial Resistance (AMR) represents a global health threat, which continues to worsen, despite the emerging realisation of the severity and magnitude of this problem, including beyond expert spheres. In this position paper, 17 organizations present 6 recommendations to the European Commission, on the EU Pharmaceutical strategy.

23 / 11 / 2021

FEAM Newsletter – November 2021

In the November issue of our newsletter, we highlight the FEAM Forum Annual Lecture, the publication of the report on Health Inequalities and the participation of Professor Stefan Constantinescu, in the European Cancer Summit.

19 / 11 / 2021

Summary report: The impact of COVID-19 on routine vaccination

On 26 October, the FEAM Forum organised a webinar on the Impact of COVID-19 on routine vaccination, which focused on the lessons learned from this pandemic, with the aim of improving vaccine planning and communication across Europe.

17 / 11 / 2021

Report: In the Health Inequalities Research: New methods, better insights?

In the Health Inequalities Research: New methods, better insights? report, published on 15 November, experts from the European Federation of Academies of Sciences and Humanities (ALLEA) and the Federation of European Academies of Medicine (FEAM) evaluate scientific methods to study health inequalities with the aim of helping to narrow the health gap across Europe.

14 / 11 / 2021

Summary Report: PERISCOPE Workshop on COVID-19 health inequalities in Europe

This is the Summary Report of the PERISCOPE Workshop on COVID-19 health inequalities in Europe, held on the 29h of September 2021. This workshop is the result of a joint collaboration between 5 different partners under the umbrella of the research project PERISCOPE. PERISCOPE is a European funded project aiming at investigating the broad behavioural and socioeconomic impacts of the current COVID-19 pandemic. It brings together 32 partners from all over Europe, coming from a wide array of expertise.

22 / 10 / 2021

KNAW advisory report “Greater Efficiency through Innovation”

Royal Netherlands Academy of Arts and Sciences expertise in the field of drug development is too fragmented, with researchers’ efforts to get their discoveries to the patient being frustrated. National coordination is therefore needed to support researchers and promote cooperation. That will make drug development faster and more effective and give patients better access to new therapies. This is what the Academy calls for in its new advisory report “Greater Efficiency through Innovation”.

05 / 10 / 2021

FEAM Newsletter – September 2021

In the September issue of our newsletter, we introduce FEAM's new board, our two new colleagues, Dr. Emma Martinez and Patrick Hurst, and look at the various areas of FEAM's work.

16 / 09 / 2021

FEAM Statement on Shortages of Medicines

In a statement published on 9 September 2021, the FEAM and its Member Academies set out a list of recommendations to address the challenge of shortages of medicines.

07 / 09 / 2021

Remove obstacles to sharing health data with researchers outside of the European Union

The lead authors of the report "International Sharing of Personal Health Data for Research" published a comment in the journal Nature Medicine. The paper, presented by members of FEAM, ALLEA and EASAC, summarises the main findings of the joint report, published last April.

23 / 08 / 2021

Recommendations from the French Academy of Pharmacy on Unavailability of Indispensable Medicine

02 / 08 / 2021

IAP – Statement on Regenerative Medicine

30 / 07 / 2021

European Health Stakeholder Group Statement on the UK data protection regime

The European Health Stakeholder Group welcomes the results of the Article 93 Committee vote on the UK data protection regime on 16 June. EU Member States voted unanimously in favour to approve the adequacy decision which means that the flow of personal data from the EU to the UK will continue uninterrupted post-Brexit.

22 / 06 / 2021